Johnson Controls Reports Strong Q1 Results; Raises FY26 Guidance
Q1 sales increased 7% and organic sales increased 6%* Q1 GAAP EPS of $0.90; Q1 Adjusted EPS* of $0.89 Q1 Orders +39% organically year-over-year Backlog of $18.2... Read more.
Vietjet selects RTX’s Pratt & Whitney to power 44 additional A320neo family aircraft
Order includes 12-year maintenance agreement SINGAPORE, Feb. 4, 2026 /PRNewswire/ — Vietjet Air and Pratt & Whitney, an RTX (NYSE: RTX) business, announce... Read more.
GameChange Solar selected to supply trackers for 1,290 MWp Bisha Solar PV Plant in Saudi Arabia
DUBAI, UAE, Feb. 4, 2026 /PRNewswire/ — GameChange Solar, a leading global supplier of solar tracker and fixed-tilt racking technology, announced that it has... Read more.
RTX’s Raytheon partners with Department of War on five landmark agreements to expand critical munition production
Up-to-seven-year deals to increase annual production of Tomahawk, AMRAAM, SM-3 Block IB, SM-3 Block IIA, SM-6 TUCSON, Ariz., Feb. 4, 2026 /PRNewswire/ — Raytheon,... Read more.
Bio-Techne Releases Second Quarter Fiscal 2026 Results
MINNEAPOLIS, Feb. 4, 2026 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ending December... Read more.
CGI expands presence in Atlanta with Stratfield Consulting
Stock Market SymbolsGIB.A (TSX)GIB (NYSE)cgi.com/newsroom ATLANTA, Feb. 4, 2026 /PRNewswire/ – CGI (TSX: GIB.A) (NYSE: GIB), one of the world’s largest... Read more.
Cognizant Reports Fourth Quarter and Full-Year 2025 Results
Exceeds fourth quarter revenue guidance and full year guidance across revenue, adjusted operating margin, and adjusted EPS Fourth quarter revenue of $5.3 billion... Read more.
Bio-Techne Declares Dividend
MINNEAPOLIS, Feb. 4, 2026 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08... Read more.
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
– Additional CALLIPER MRI Analyses Show Reductions for Vidofludimus Calcium in Acute and Chronic Inflammatory Disease Activity – – CALLIPER Subset Data Demonstrate... Read more.
Equifax Delivers Fourth Quarter 2025 Revenue Growth of 9% Despite Weaker U.S. Hiring and Mortgage Markets
ATLANTA, Feb. 4, 2026 /PRNewswire/ — Equifax® (NYSE: EFX) today announced financial results for the quarter and full year ended December 31, 2025. Fourth... Read more.